Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

353 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Determining host factors contributing to disease severity in a family cluster of 29 hospitalized SARS-CoV-2 patients: Could genetic factors be relevant in the clinical course of COVID-19?
Ikitimur H, Borku Uysal B, Cengiz M, Ikitimur B, Uysal H, Ozcan E, Islamoglu MS, Seyhan S, Yavuzer H, Yavuzer S. Ikitimur H, et al. Among authors: ozcan e. J Med Virol. 2021 Jan;93(1):357-365. doi: 10.1002/jmv.26106. Epub 2020 Oct 14. J Med Virol. 2021. PMID: 32492209 Free PMC article.
Effect of oral l-Glutamine supplementation on Covid-19 treatment.
Cengiz M, Borku Uysal B, Ikitimur H, Ozcan E, Islamoğlu MS, Aktepe E, Yavuzer H, Yavuzer S. Cengiz M, et al. Among authors: ozcan e. Clin Nutr Exp. 2020 Oct;33:24-31. doi: 10.1016/j.yclnex.2020.07.003. Epub 2020 Jul 29. Clin Nutr Exp. 2020. PMID: 32835086 Free PMC article.
Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy?
Dülgar Ö, Öven BB, Atcı MM, Arıkan R, Ay S, Ayhan M, Selvi O, Ozyukseler DT, Bayram E, Özcan E, Yasin Aİ, Gümüş M. Dülgar Ö, et al. Among authors: ozcan e. Expert Rev Anticancer Ther. 2022 Jul;22(7):773-780. doi: 10.1080/14737140.2022.2076670. Epub 2022 Jun 1. Expert Rev Anticancer Ther. 2022. PMID: 35543015
Prognostic Factors for Survival in Transverse Colon Cancers.
Küçükarda A, Gökyer A, Sayın S, Gökmen İ, Özcan E, Köstek O, Hacıoğlu MB, Uzunoğlu S, Çiçin İ, Erdoğan B. Küçükarda A, et al. Among authors: ozcan e. J Gastrointest Cancer. 2022 Mar;53(1):31-40. doi: 10.1007/s12029-021-00675-1. Epub 2021 Jul 24. J Gastrointest Cancer. 2022. PMID: 34302255
An experimental study: the effect of S. boulardii on abemaciclibinduced diarrhea.
Cakcak İE, Aytın YE, Sayın S, Küçükarda A, Gökyer A, Gökmen İ, Özcan E, Korkmaz S, Taştekin E, Çiçin İ. Cakcak İE, et al. Among authors: ozcan e. Turk J Med Sci. 2023 Feb;53(1):51-57. doi: 10.55730/1300-0144.5557. Epub 2023 Feb 22. Turk J Med Sci. 2023. PMID: 36945921 Free PMC article.
The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study).
Hizal M, Bilgin B, Paksoy N, Atcı MM, Kahraman S, Kılıçkap S, Güven DC, Keskinkılıç M, Ayhan M, Eren Ö, Mustafayev FNA, Yaman Ş, Bayram E, Ertürk İ, Özcan E, Korkmaz M, Akagündüz B, Erdem D, Telli TA, Aksoy A, Üskent N, Baytemür NK, Gülmez A, Aydın D, Şakalar T, Arak H, Tatlı AM, Ergün Y, Ak N, Ünal Ç, Özgün MA, Yalçın B, Öztop İ, Algın E, Sakin A, Aydıner A, Yumuk PF, Şendur MAN. Hizal M, et al. Among authors: ozcan e. J Cancer Res Clin Oncol. 2023 Jul;149(8):4141-4148. doi: 10.1007/s00432-022-04252-2. Epub 2022 Sep 1. J Cancer Res Clin Oncol. 2023. PMID: 36048274 Free PMC article.
353 results